Silence Therapeutics Plc - American Depository Share (NQ:SLN)

19.76 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 4 5 6 7 Next >

Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗

September 08, 2022

Via Benzinga

Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate ↗

September 08, 2022

Silence Therapeutics (NASDAQ: SLN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its lead candidate SLN124 for the treatment of polycythemia vera...

Via Benzinga

Silence Therapeutics to Participate in September Investment Conferences

September 08, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces FDA Fast Track Designation for SLN124, a Novel Investigational siRNA Therapy for the Treatment of Polycythemia Vera

September 08, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Posts First Human Data For Cardiovascular Candidate ↗

February 09, 2022

Silence Therapeutics plc (NASDAQ: SLN) showed that its RNAi technology could

Via Benzinga

Workday, Electronic Arts, Ulta Beauty And Some Other Big Stocks Moving Higher On Friday ↗

August 26, 2022

Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

August 18, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

Via Benzinga

Silence Therapeutics Announces Pricing of Underwritten Offering

August 11, 2022

From Silence Therapeutics plc

Via Business Wire

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

Silence Therapeutics to Present at Jefferies Healthcare Conference

June 02, 2022

From Silence Therapeutics plc

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright Global Investment Conference

May 18, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Reports First Quarter 2022 Results

May 16, 2022

From Silence Therapeutics plc

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 10, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 28, 2022

Via Benzinga

74 Biggest Movers From Yesterday ↗

April 29, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

April 27, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...

Via Benzinga

61 Biggest Movers From Yesterday ↗

April 28, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...

Via Benzinga

Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration

April 25, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference

April 06, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces Publication in the Journal of the American Medical Association Highlighting Results From SLN360 Phase 1 Study in Healthy Adults With High Lipoprotein(a)

April 03, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces Detailed Results From SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at the American College of Cardiology (ACC.22) Annual Meeting

April 03, 2022

From Silence Therapeutics plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022 ↗

March 31, 2022

Upgrades

Via Benzinga

Silence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501

March 23, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Reports Fourth Quarter and Full Year 2021 Results

March 17, 2022

From Silence Therapeutics plc

Via Business Wire

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 22, 2022

During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...

Via Benzinga

Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer

February 21, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces Positive Topline Data in SLN360 Phase 1 Single-Ascending Dose Study in Healthy Adults with High Lipoprotein(a)

February 09, 2022

From Silence Therapeutics plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.